Summary
This filing is an amendment to a previous 8-K report for Regeneron Pharmaceuticals, Inc. (REGN), dated January 25, 2001. The primary purpose of this amendment is to correct a minor typographical error in a press release that was originally issued earlier on the same day. The revised press release, dated January 25, 2001, is attached as Exhibit 99.1 to this filing. For investors, this is a very minor administrative update. It does not introduce new material information regarding the company's financial performance, operations, strategic initiatives, or significant business events. The correction is purely textual and does not alter the substance of the original announcement. Investors should refer to the original 8-K filing or subsequent reports for substantive business updates.
Key Highlights
- 1Amendment to a previously filed 8-K report by Regeneron Pharmaceuticals, Inc.
- 2The amendment corrects a minor typographical error in a press release issued on January 25, 2001.
- 3A revised press release, dated January 25, 2001, is attached as Exhibit 99.1.
- 4The event date for the earliest event reported is January 25, 2001.
- 5This filing is an administrative correction and does not contain new material financial or operational information.
- 6The company's principal executive offices are located at 777 Old Saw Mill River Rd, Tarrytown NY.